Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bayer Aktienges ADR (BAYRY)

Bayer Aktienges ADR (BAYRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 57,333,176
  • Shares Outstanding, K 3,730,200
  • Annual Sales, $ 47,291 M
  • Annual Income, $ -11,988 M
  • 60-Month Beta 1.29
  • Price/Sales 1.19
  • Price/Cash Flow 2.61
  • Price/Book 1.67
Trade BAYRY with:
  • Price/Earnings ttm 8.44
  • Earnings Per Share ttm 1.85
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/03/21
  • Annual Dividend & Yield 0.41 (2.66%)
  • Most Recent Dividend 0.415 on 04/28/21
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.47
  • Number of Estimates 2
  • High Estimate 0.47
  • Low Estimate 0.47
  • Prior Year 0.44
  • Growth Rate Est. (year over year) +6.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.2600 +0.72%
on 06/22/21
17.2600 -10.95%
on 05/24/21
-1.6600 (-9.75%)
since 05/21/21
3-Month
15.2600 +0.72%
on 06/22/21
17.3400 -11.36%
on 05/14/21
-0.5500 (-3.45%)
since 03/22/21
52-Week
11.6500 +31.93%
on 10/30/20
21.0500 -26.98%
on 06/24/20
-4.0800 (-20.98%)
since 06/22/20

Most Recent Stories

More News
Bayer (BAYRY) Files Applications in US & EU for Cancer Treatment

Bayer (BAYRY) submits an sNDA in the United States and an MAA in Europe for the combo of copanlisib and rituximab to treat two types of cancer indication.

RHHBY : 46.8000 (-1.43%)
BAYRY : 15.3700 (-1.60%)
RGEN : 197.15 (+0.51%)
TECH : 441.88 (+0.38%)
Anti-Hypertensive Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Reportlinker.com announces the release of the report "Anti-Hypertensive Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030" - https://www.reportlinker.com/p06097019/?utm_source=GNW

BAYRY : 15.3700 (-1.60%)
DSNKY : 22.9500 (+1.15%)
MRK : 76.19 (-0.73%)
NVS : 93.13 (-0.83%)
PFE : 39.61 (+0.48%)
Drugs For Hormonal Replacement Therapy Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Reportlinker.com announces the release of the report "Drugs For Hormonal Replacement Therapy Global Market Report 2021: COVID-19 Impact And Recovery To 2030" - https://www.reportlinker.com/p06097025/?utm_source=GNW...

BAYRY : 15.3700 (-1.60%)
LLY : 221.44 (-0.55%)
NVO : 82.16 (-0.59%)
PFE : 39.61 (+0.48%)
Kidney Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030

Reportlinker.com announces the release of the report "Kidney Cancer Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030" - https://www.reportlinker.com/p06097027/?utm_source=GNW

BAYRY : 15.3700 (-1.60%)
EXEL : 22.83 (+0.40%)
NVS : 93.13 (-0.83%)
PFE : 39.61 (+0.48%)
Disposable Hospital Supplies Global Market Report 2021: COVID-19 Implications And Growth To 2030

Reportlinker.com announces the release of the report "Disposable Hospital Supplies Global Market Report 2021: COVID-19 Implications And Growth To 2030" - https://www.reportlinker.com/p06097046/?utm_source=GNW...

ABT : 110.96 (-0.43%)
BAYRY : 15.3700 (-1.60%)
CAH : 56.69 (+0.02%)
HRC : 112.84 (+0.54%)
Global Acute Otitis Media Treatment Market Size, Share Remuneration to Surge At 5% CAGR Through 2025 - Industry Report

Selbyville, Delaware. The report Acute Otitis Media Treatment Market Size and Analysis maintains enhanced dynamics and is overshadowed by a top player across the globe. The research report provides Acute...

ABT : 110.96 (-0.43%)
BAYRY : 15.3700 (-1.60%)
LLY : 221.44 (-0.55%)
GSK : 39.08 (-1.76%)
NVS : 93.13 (-0.83%)
PDP.VN : 0.300 (+1.69%)
PFE : 39.61 (+0.48%)
Choroidal Neovascularization Market: Facts, Figures and Analytical Insights, 2020 to 2027| Regeneron Pharmaceuticals Inc., Sanwa Kagaku Kenkyusho Co. Ltd., Gilead Sciences Inc and Others

The recent published research report sheds light on critical aspects of the such as vendor landscape, competitive strategies, market drivers and challenges along with the regional analysis. The report...

BAYRY : 15.3700 (-1.60%)
GILD : 67.05 (-0.45%)
NVS : 93.13 (-0.83%)
PFE : 39.61 (+0.48%)
QLTI : 1.95 (+6.56%)
REGN : 534.02 (-0.05%)
VRX.TO : 30.80 (-3.33%)
Global Mycosis Fungoides Market (2021 to 2029) - Featuring Bayer, Elorac and Sanofi Among Others

/PRNewswire/ -- The report has been added to offering.

ALPMF : 17.6600 (+2.50%)
BAYRY : 15.3700 (-1.60%)
SNGXD : 4.1500 (-5.68%)
VAR : 177.07 (-0.02%)
CureVac (CVAC) Plummets on Disappointing COVID-19 Vaccine Data

CureVac (CVAC) down as it announces that its first-generation COVID-19 vaccine candidate, CVnCoV, did not meet the prespecified statistical success criteria in a phase IIb/III study.

GSK : 39.08 (-1.76%)
PFE : 39.61 (+0.48%)
BAYRY : 15.3700 (-1.60%)
CVAC : 58.10 (-2.63%)
Immune Health Supplements Market Size Is Projected to Reach USD 31.50 Billion by 2028, Exhibiting a CAGR of 6.6%

The global immune health supplements market is set to gain momentum from the rising awareness of clean label products infused with minimally processed and natural ingredients. In May 2020, for instance,...

BAYRY : 15.3700 (-1.60%)
BLMMF : 103.4800 (unch)
GLAPF : 17.2500 (+0.29%)
USNA : 101.16 (+0.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 15.6167
2nd Resistance Point 15.5233
1st Resistance Point 15.4467
Last Price 15.3700
1st Support Level 15.2767
2nd Support Level 15.1833
3rd Support Level 15.1067

See More

52-Week High 21.0500
Fibonacci 61.8% 17.4592
Fibonacci 50% 16.3500
Last Price 15.3700
Fibonacci 38.2% 15.2408
52-Week Low 11.6500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar